Serum butyrylcholinesterase activity as a predictor of severity and mortality in COVID-19 patients

Serum butyrylcholinesterase activity as a predictor of severity and mortality in COVID-19 patients

Abstract Previous studies suggest that butyrylcholinesterase (BChE), an enzyme involved in the cholinergic anti-inflammatory pathway, may be linked to inflammation, disease severity, and risk of death in COVID-19 patients. Extending earlier work on BChE and COVID-19 severity, this study investigates...

Full description

Saved in:
Bibliographic Details
Main Authors: Tomáš Fazekaš, Lucia Kováčik, Morteza Motahari Rad, Xavier Gabaldó Barrios, Simona Mihaela Iftimie, Jordi Camps, Anna Hrabovská
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
COVID-19
Butyrylcholinesterase
Severity
Mortality
Symptoms
Ellman’s assay
Online Access:https://doi.org/10.1038/s41598-025-07017-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-07017-2

Similar Items